Evidence map›Paper›PMID 19596142›Full record

ArticleThe Journal of allergy and clinical immunology2009

Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16.

Jennifer P DeMore, Elizabeth H Weisshaar, Rose F Vrtis, Cheri A Swenson, Michael D Evans, Allison Morin, Elizabeth Hazel, Jack A Bork, Sujani Kakumanu, Ronald Sorkness and 2 more

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of allergy and clinical immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05775952 (Comparison of Airway Remodeling Mediators Following Experimental Human Rhinovirus Infection in Subjects With Mild to Moderate Asthma and Healthy, Non-asthmatic Control Subjects), which is not on this map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05775952 unknown statusnot on this mapstarted 2011, after this paper: background citation

Comparison of Airway Remodeling Mediators Following Experimental Human Rhinovirus Infection in Subjects With Mild to Moderate Asthma and Healthy, Non-asthmatic Control Subjects

TypeobservationalSponsorUniversity of CalgaryRan2011 to 2024Enrolled24ConditionsAsthma, Respiratory DiseaseArmsHRV-39
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma ExacerbationsAmerican journal of respiratory and critical care medicine · 2021
    Trial
  4. Trial
  5. Rhinovirus-16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptoms.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Trial
  6. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2011
    Trial
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. T-cell responses in asthma exacerbations.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Review
  14. Review
  15. ILC2s in Virus-induced Asthma Exacerbations: A Starring or Supportive Role?American journal of respiratory and critical care medicine · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Human TThe Journal of allergy and clinical immunology · 2020
    Article
  20. Exacerbation-Prone Asthma.The journal of allergy and clinical immunology. In practice · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jennifer P DeMoreDepartment of Medicine, University of Wisconsin-Madison, Madison, Wis, USA. jpd@medicine.wisc.edu
Elizabeth H Weisshaar
Rose F Vrtis
Cheri A Swenson
Michael D Evans
Allison Morin
Elizabeth Hazel
Jack A Bork
Sujani Kakumanu
Ronald Sorkness
William W Busse
James E Gern
University of Wisconsin–Madison · USWilliam S. Middleton Memorial Veterans Hospital · US

Funding

RV-Mediated Mechanisms of Neutrophil Motility /InflammatU19AI070503 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E. · 2006 to 2010
$6.8M
Rhinovirus infection of bronchial epithelium &IL-8 mRNAP01AI050500 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI GERN, JAMES E. · 2001 to 2005
$5.6M
NIAID NIH HHS P01 AI050500NIAID NIH HHS P01 AI50500NIAID NIH HHS U19 AI070503
6 · The paper itself

Abstract

backgroundRhinovirus infections are frequent causes of asthma exacerbations.

objectiveThis study was conducted to test whether subjects with and without allergic asthma have different responses to infection and to identify baseline patient risk factors that predict cold outcomes.

methodsTwenty subjects with mild persistent allergic asthma and 18 healthy subjects were experimentally inoculated with rhinovirus-16. Subjects were evaluated at baseline, during the acute infection, and during recovery for asthma and cold symptoms by using a validated questionnaire. Sputum and nasal lavage fluid were evaluated for viral shedding, cytokines, and cellular inflammation.

resultsThere were no group-specific significant differences in peak cold symptom scores (10.0 +/- 5.8 vs 11.1 +/- 6.2, asthmatic vs healthy subjects), peak nasal viral titers (log(10) 4.3 +/- 0.8 vs 3.7 +/- 1.4 50% tissue culture infective dose/mL, respectively), or changes in peak flow during the study (10% +/- 10% vs 8% +/- 6%, respectively). Rhinovirus-16 infection increased peak asthma index values in the asthmatic group (median, 6 --> 13; P = .003) but only marginally in the healthy group (median, 4 --> 7; P = .09). More asthmatic subjects had detectable eosinophils in nasal lavage and sputum samples at baseline and during infection, but otherwise, cellular and cytokine responses were similar. Baseline sputum eosinophilia and CXCL8 (IL-8) levels were positively associated with cold symptoms, whereas CCL2 (monocyte chemotactic protein 1) levels were inversely associated with nasal viral shedding.

conclusionsThese findings suggest that subjects with mild allergic asthma and healthy subjects have similar cold symptoms and inflammatory and antiviral responses. In addition, eosinophilia and other selective baseline measures of airway inflammation in subjects with or without asthma might predict respiratory outcomes with rhinovirus infection.

Indexed as

RhinovirusAdultAsthmaCommon ColdCytokinesEosinophilsFemaleHumansImmunoglobulin EMaleNasal Lavage FluidPicornaviridae InfectionsRNA, ViralSputumCytokinesImmunoglobulin ERNA, Viral

Identifiers

PMID19596142
PMCPMC2737589
OpenAlexW2137313291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.